Form D · Biotechnology
Anya Holding LLC
New York, NY · CIK 0002079053
Offering snapshot reported Jul 31, 2025 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 16, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2025 | Initial | $0 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553403
Includes the issuance of all 20,000 shares of Issuer's Class A Common Interests as consideration in connection with the contribution by seller to Issuer. Please refer to Item 10 for additional information.
Source: Form D, filed Jul 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vipin Agarwal | Executive |
| Joep Bruins | Director |
| Abhay Pandey | Director, Executive |
| Robert Wolff | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
228 E 45 Th Street Rm 9 E
New York, NY, 10017
New York, NY, 10017